196 related articles for article (PubMed ID: 37121574)
1. IL-8 concurrently promotes idiopathic pulmonary fibrosis mesenchymal progenitor cell senescence and PD-L1 expression enabling escape from immune cell surveillance.
Yang L; Xia H; Gilbertsen A; Smith K; Racila E; Bitterman PB; Henke CA
Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L849-L862. PubMed ID: 37121574
[TBL] [Abstract][Full Text] [Related]
2. IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity.
Yang L; Herrera J; Gilbertsen A; Xia H; Smith K; Benyumov A; Bitterman PB; Henke CA
Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L127-L136. PubMed ID: 28860143
[TBL] [Abstract][Full Text] [Related]
3. A CD44/Brg1 nuclear complex confers mesenchymal progenitor cells with enhanced fibrogenicity in idiopathic pulmonary fibrosis.
Yang L; Xia H; Smith K; Gilbertsen A; Beisang D; Kuo J; Bitterman PB; Henke CA
JCI Insight; 2021 May; 6(9):. PubMed ID: 33822772
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan/CD44 axis regulates S100A4-mediated mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis.
Xia H; Herrera J; Smith K; Yang L; Gilbertsen A; Benyumov A; Racila E; Bitterman PB; Henke CA
Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L926-L941. PubMed ID: 33719561
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia enhances IPF mesenchymal progenitor cell fibrogenicity via the lactate/GPR81/HIF1α pathway.
Yang L; Gilbertsen A; Xia H; Benyumov A; Smith K; Herrera J; Racila E; Bitterman PB; Henke CA
JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36656644
[TBL] [Abstract][Full Text] [Related]
6. Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis.
Xia H; Gilbertsen A; Herrera J; Racila E; Smith K; Peterson M; Griffin T; Benyumov A; Yang L; Bitterman PB; Henke CA
J Clin Invest; 2017 Jun; 127(7):2586-2597. PubMed ID: 28530639
[TBL] [Abstract][Full Text] [Related]
7. Brg1/PRMT5 nuclear complex epigenetically regulates FOXO1 in IPF mesenchymal progenitor cells.
Jbeli AH; Yang L; Xia H; Gilbertsen AJ; Bitterman PB; Henke CA
Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L344-L352. PubMed ID: 38252663
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of the IPF mesenchymal progenitor cell nuclear proteome identifies abnormalities in key nodal proteins that underlie their fibrogenic phenotype.
Yang L; Gilbertsen A; Smith K; Xia H; Higgins L; Guerrero C; Henke CA
Proteomics; 2022 Jul; 22(13-14):e2200018. PubMed ID: 35633524
[TBL] [Abstract][Full Text] [Related]
9. DNA-PKcs modulates progenitor cell proliferation and fibroblast senescence in idiopathic pulmonary fibrosis.
Habiel DM; Hohmann MS; Espindola MS; Coelho AL; Jones I; Jones H; Carnibella R; Pinar I; Werdiger F; Hogaboam CM
BMC Pulm Med; 2019 Aug; 19(1):165. PubMed ID: 31464599
[TBL] [Abstract][Full Text] [Related]
10. Single-cell RNA sequencing reveals that lung mesenchymal progenitor cells in IPF exhibit pathological features early in their differentiation trajectory.
Beisang DJ; Smith K; Yang L; Benyumov A; Gilbertsen A; Herrera J; Lock E; Racila E; Forster C; Sandri BJ; Henke CA; Bitterman PB
Sci Rep; 2020 Jul; 10(1):11162. PubMed ID: 32636398
[TBL] [Abstract][Full Text] [Related]
11. Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.
Cárdenes N; Álvarez D; Sellarés J; Peng Y; Corey C; Wecht S; Nouraie SM; Shanker S; Sembrat J; Bueno M; Shiva S; Mora AL; Rojas M
Stem Cell Res Ther; 2018 Sep; 9(1):257. PubMed ID: 30257725
[TBL] [Abstract][Full Text] [Related]
12. Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis.
Karampitsakos T; Galaris A; Chrysikos S; Papaioannou O; Vamvakaris I; Barbayianni I; Kanellopoulou P; Grammenoudi S; Anagnostopoulos N; Stratakos G; Katsaras M; Sampsonas F; Dimakou K; Manali ED; Papiris S; Tourki B; Juan-Guardela BM; Bakakos P; Bouros D; Herazo-Maya JD; Aidinis V; Tzouvelekis A
Respir Res; 2023 Nov; 24(1):279. PubMed ID: 37964265
[TBL] [Abstract][Full Text] [Related]
13. The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?
Jiang A; Liu N; Wang J; Zheng X; Ren M; Zhang W; Yao Y
Front Immunol; 2022; 13():1022228. PubMed ID: 36544757
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 upregulation promotes drug-induced pulmonary fibrosis by inhibiting vimentin degradation.
Li Q; Deng MS; Wang RT; Luo H; Luo YY; Zhang DD; Chen KJ; Cao XF; Yang GM; Zhao TM; Xu B; Xu CX; Wang JM
Pharmacol Res; 2023 Jan; 187():106636. PubMed ID: 36586643
[TBL] [Abstract][Full Text] [Related]
15. PD-1 up-regulation on CD4
Celada LJ; Kropski JA; Herazo-Maya JD; Luo W; Creecy A; Abad AT; Chioma OS; Lee G; Hassell NE; Shaginurova GI; Wang Y; Johnson JE; Kerrigan A; Mason WR; Baughman RP; Ayers GD; Bernard GR; Culver DA; Montgomery CG; Maher TM; Molyneaux PL; Noth I; Mutsaers SE; Prele CM; Peebles RS; Newcomb DC; Kaminski N; Blackwell TS; Van Kaer L; Drake WP
Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257954
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of PD-L1 in Senescence and Aging.
Onorati A; Havas AP; Lin B; Rajagopal J; Sen P; Adams PD; Dou Z
Mol Cell Biol; 2022 Oct; 42(10):e0017122. PubMed ID: 36154662
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 mediates lung fibroblast to myofibroblast transition through Smad3 and β-catenin signaling pathways.
Guo X; Sunil C; Adeyanju O; Parker A; Huang S; Ikebe M; Tucker TA; Idell S; Qian G
Sci Rep; 2022 Feb; 12(1):3053. PubMed ID: 35197539
[TBL] [Abstract][Full Text] [Related]
18. Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients.
Atanasova E; Milosevic D; Bornschlegl S; Krucker KP; Jacob EK; Carmona Porquera EM; Anderson DK; Egan AM; Limper AH; Dietz AB
Stem Cell Res Ther; 2022 Jan; 13(1):45. PubMed ID: 35101101
[TBL] [Abstract][Full Text] [Related]
19. Regulatory Effect of PD1/PD-Ligand 1 (PD-L1) on Treg Cells in Patients with Idiopathic Pulmonary Fibrosis.
Wang B; Bai W; Ma H; Li F
Med Sci Monit; 2021 Jan; 27():e927577. PubMed ID: 33386384
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of miR-199a-5p rejuvenates aged mesenchymal stem cells derived from patients with idiopathic pulmonary fibrosis and improves their therapeutic efficacy in experimental pulmonary fibrosis.
Shi L; Han Q; Hong Y; Li W; Gong G; Cui J; Mao M; Liang X; Hu B; Li X; Luo Q; Zhang Y
Stem Cell Res Ther; 2021 Feb; 12(1):147. PubMed ID: 33632305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
